About Immuto Scientific
Immuto Scientific is a company based in Madison (United States) founded in 2018 by Daniel Benjamin and Faraz Choudhury. Immuto Scientific has raised $2.3 million across 3 funding rounds from investors including HHS, Wisconsin Investment Partners and WARF. The company has 7 employees as of December 31, 2022. Immuto Scientific offers products and services including PLIMB Platform and Epitope Mapping Service. Immuto Scientific operates in a competitive market with competitors including Cyrus Biotechnology, Vividion Therapeutics, Seer, Biognosys and ProteinSimple, among others.
- Headquarter Madison, United States
- Employees 7 as on 31 Dec, 2022
- Founders Daniel Benjamin, Faraz Choudhury
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.3 M (USD)
in 3 rounds
-
Latest Funding Round
$2.3 M (USD), Seed
Oct 12, 2021
-
Investors
HHS
& 6 more
-
Employee Count
7
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Immuto Scientific
Immuto Scientific offers a comprehensive portfolio of products and services, including PLIMB Platform and Epitope Mapping Service.
Enables high-resolution protein structure and interaction analysis.
Maps epitopes for antibody development and protein interactions.
People of Immuto Scientific
Unlock access to complete
Unlock access to complete
Leadership Team
4 people
Board Team
3 people
Scientist Team
3 people
CTO Team
1 people
Sr. Team
1 people
Unlock access to complete
Funding Insights of Immuto Scientific
Immuto Scientific has successfully raised a total of $2.3M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $2.3 million completed in October 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Immuto Scientific
Immuto Scientific has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Wisconsin Investment Partners and WARF.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Angel investment and business incubation services are provided.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
A seed accelerator program is operated to support startups.
|
Locked | Locked | Locked |
Investor details for Immuto Scientific
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Immuto Scientific
Investment portfolio details for Immuto Scientific
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Immuto Scientific
Detailed financials for Immuto Scientific
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Immuto Scientific Comparisons
Peer comparison for Immuto Scientific
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Immuto Scientific
Immuto Scientific operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cyrus Biotechnology, Vividion Therapeutics, Seer, Biognosys and ProteinSimple, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based protein-modeling software is developed for drug discovery.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
Proteomics platform developed for early cancer and neurological disease detection.
|
|
| Locked | Locked | Locked |
Proteomics services are delivered via discovery and targeted platforms.
|
|
| Locked | Locked | Locked |
Provider tools to help researchers with protein analysis
|
|
| Locked | Locked | Locked |
Small molecule oncology therapeutics are developed for cancer treatment.
|
Detailed competitors of Immuto Scientific
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Immuto Scientific
Complete news archive for Immuto Scientific
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Immuto Scientific
Immuto Scientific was founded in 2018.
Immuto Scientific is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.
Daniel Benjamin is the current CEO of Immuto Scientific. They have also founded this company.
Immuto Scientific is a funded company, having raised a total of $2.3M across 3 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Immuto Scientific is 7.
Immuto Scientific was established in 2018 in Madison, United States, within the biotechnology sector. Digital platforms for drug discovery are developed and offered to support researchers in pharmaceutical processes. Operations center on computational tools that streamline research workflows. The company is led by co-founders Daniel Benjamin and Faraz Choudhury, who serve as joint CEOs. Focus remains on enabling efficient scientific investigations through technology.
Immuto Scientific's top competitors include Vividion Therapeutics, Cyrus Biotechnology and Biognosys.
Immuto Scientific offers PLIMB Platform and Epitope Mapping Service.
Immuto Scientific has 7 investors. Key investors include HHS, Wisconsin Investment Partners, WARF, unknown, and BrightStar Wisconsin Foundation.